Cost Effectiveness of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor For The Treatment of Heart Failure From Public Health Perspective in Chile
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1778
https://www.valueinhealthjournal.com/article/S1098-3015(16)33144-8/fulltext
Title :
Cost Effectiveness of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor For The Treatment of Heart Failure From Public Health Perspective in Chile
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33144-8&doi=10.1016/j.jval.2016.09.1778
First page :
A656
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1679